ask="3.4500"
ask_size="100"
average_daily_volume="9537"
bid="N/A"
bid_size="N/A"
book_value="2.6090"
change="-0.0699"
change_from_200_day_moving_average="-0.9588"
change_from_50_day_moving_average="-0.4887"
change_from_52_week_high="-2.3399"
change_From_52_week_low="0.7500"
change_in_percent="-2.0379%"
close="3.3601"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.7700"
ebitda="-19.70M"
eps_estimate_current_year="-1.6500"
eps_estimate_next_quarter="-0.4400"
eps_estimate_next_year="-1.7000"
ex_dividend_date="N/A"
float_shares="1878000"
high="3.5000"
high_52_weeks="5.7000"
last_trade_date="1/27/2017"
last_trade_price="3.3601"
last_trade_size="1500"
last_trade_time="10:08am"
low="3.3601"
low_52_weeks="2.6101"
market_capitalization="39.40M"
moving_average_200_day="4.3189"
moving_average_50_day="3.8488"
name="Nexvet Biopharma plc"
notes="N/A"
one_year_target_price="8.0000"
open="3.5000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-22.2001%"
percent_change_from_50_day_moving_average="-12.6966%"
percent_change_from_52_week_high="-41.0509%"
percent_change_from_52_week_low="+28.7345%"
previous_close="3.4300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3147"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11726000"
short_ratio="10.7800"
stock_exchange="NGM"
symbol="NVET"
volume="2725"
weeks_range_52="2.6101 - 5.7000"
